TBC
IBB icon

Ted Buchan & Co’s iShares Biotechnology ETF IBB Stock Holding History

Ted Buchan & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,557
Closed -$323K – 89
2025
Q2 		$323K Sell
2,557
-958
-27% -$118K 0.13% 77
2025
Q1 		$450K Buy
3,515
+870
+33% +$118K 0.21% 60
2024
Q4 		$350K Sell
2,645
-60
-2% -$8.44K 0.17% 66
2024
Q3 		$394K Sell
2,705
-105
-4% -$15.2K 0.19% 64
2024
Q2 		$386K Sell
2,810
-702
-20% -$93.7K 0.21% 58
2024
Q1 		$482K Sell
3,512
-1,188
-25% -$162K 0.3% 55
2023
Q4 		$638K Buy
+4,700
New +$573K 0.47% 45

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ted Buchan & Co's IBB Position: Q3 2025 in Review

Ted Buchan & Co sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 2,557 shares — an estimated $323K sold.

Ted Buchan & Co first reported a position in IBB in Q4 2023 and held it in 7 quarters. The position peaked at $638K in Q4 2023. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Ted Buchan & Co reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Ted Buchan & Co sold 2,557 iShares Biotechnology ETF shares in Q3 2025, an estimated $323K.
  • Ted Buchan & Co first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 7 quarters.
  • Ted Buchan & Co's iShares Biotechnology ETF position peaked at $638K in Q4 2023.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Ted Buchan & Co's 13F filing for Q3 2025, filed 12 Nov 2025.